Up to now, trans activists have been extremely successful in intimidating endocrinologists who find the lack of concern about the effects of puberty blockers and crossover hormones disturbing.
They are amazed at how quickly their freedom to speak up on this issue has been quelled. One of my endocrinologist friends has told me quite frankly that he would be in danger of losing his hospital appointment if he advised parents of a trans-presenting child to seek a period of therapeutic assessment before moving on to puberty blockers.
The Journal of Clinical Endocrinology and Metabolism (JCEM) is an organ of the Endocrine Society. And it is the Endocrine Society which has published clinical practice guidelines on the treatment of gender dysphoria for both adults and children, first in 2009 and then in revised form in 2017. These guidelines—very trans affirmative—were written in conjunction with the World Professional Organization for Transgender Health (WPATH) which is regarded by objective endocrinologists as a radical political group at its core, but which has infiltrated an otherwise responsible, science-based medical organization.
A group of concerned endocrinologists, under the leadership of California-based Dr Michael Laidlaw, an endocrinologist trained in the study of hormones and glands, who treats diseases caused by hormone imbalances in patients, has written a letter of dissent to the editor of the JCEM, which has been accepted and will be published later this month.
www.thepostmillennial.com/endocrinologists-warn-against-hormone-treatment-for-childhood-gender-dysphoria/